Abstract
Intractable pain continues to pose problems for patients with life-limiting disease. The authors review the potential role of dexmedetomidine (Precedex), an α2-adrenergic agonist, as a bridge to obtaining effective analgesia. The authors offer criteria to consider in utilizing this medication within the context of palliative care.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 384-386 |
| Number of pages | 3 |
| Journal | Journal of Pain and Palliative Care Pharmacotherapy |
| Volume | 24 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2010 |
| Externally published | Yes |
Keywords
- Dexmedetomidine
- guidelines
- pain
- palliative care
- protocol
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Dexmedetomidine: Exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS